Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study

Authors: Tianpeng Zheng, Yun Gao, Haoming Tian

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Dyslipidemia is present in people with diabetes as well as subjects with normal glucose tolerance (NGT). The purpose of this study was to investigate the relationship between lipid profiles and β cell function in Chinese individuals with NGT but without history of diabetes or prediabetes.

Methods

A total of 893 men and 1454 women aged 18–76 years living in Sichuan, China, who were not being treated with lipid-lowering drugs were enrolled in this study. Insulin sensitivity (IR) was evaluated using the homeostasis model assessment –IR (HOMA-IR), β-cell function was calculated by the following equation: ΔI30/ΔG30/ HOMA-IR (ΔI30/ΔG30: the ratio of incremental glucose and insulin 30 min after glucose intake). Multivariate linear regression analyses were performed to estimate the relationship between blood lipid and β cell function as standardized coefficients (β).

Results

β cell function decreased in men and women with increasing age. We found inverse relationships between β cell function and total cholesterol (TC) in men and women (β = −0.157 and −0.113, respectively, both p < 0.001), low-density lipoprotein–cholesterol (LDL-C; β = −0.130 and −0.068, respectively, both p < 0.001), TC/high-density lipoprotein–cholesterol (HDL-C) ratio (β = −0.084, p < 0.01 and −0.096, p < 0.001), and triglycerides (TG) (women only; β = −0.053, p < 0.05). However, β cell function was not associated with HDL-C in men or women (β = −0.034 and 0.000, respectively, both p > 0.05) or the TG/HDL-C ratio (β = −0.035 and −0.013, respectively, both p > 0.05). β cell function was significantly worse in males than in females in all age groups, except in subjects aged > 70 years.

Conclusions

Dyslipidemia is associated with dysfunction of pancreatic β cells in subjects with NGT and this is particularly evident in people with elevated TC and LDL-C levels, especially males.

Trial Registration Number

#TR-CCH-Chi CTR-CCH-00000361
Appendix
Available only for authorised users
Literature
1.
go back to reference Barrett-Connor E, Grundy SM, Holdbrook MJ: Plasma lipids and diabetes mellitus in an adult community. Epidemiology. 1982, 115: 657-663. Barrett-Connor E, Grundy SM, Holdbrook MJ: Plasma lipids and diabetes mellitus in an adult community. Epidemiology. 1982, 115: 657-663.
2.
go back to reference Betteridge DJ: Diabetic dyslipidaemia. Diabetes Obes Metab. 2000, 2 (Suppl. 1): 31-36.CrossRef Betteridge DJ: Diabetic dyslipidaemia. Diabetes Obes Metab. 2000, 2 (Suppl. 1): 31-36.CrossRef
3.
go back to reference Fryirs M, Barter PJ, Rye KA: Cholesterol metabolism and pancreatic β-cell function. Curr Opin Lipidol. 2009, 20: 159-164. 10.1097/MOL.0b013e32832ac180.CrossRefPubMed Fryirs M, Barter PJ, Rye KA: Cholesterol metabolism and pancreatic β-cell function. Curr Opin Lipidol. 2009, 20: 159-164. 10.1097/MOL.0b013e32832ac180.CrossRefPubMed
4.
go back to reference von Eckardstein A, Sibler RA: Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol. 2011, 22: 26-32. 10.1097/MOL.0b013e3283412279.CrossRefPubMed von Eckardstein A, Sibler RA: Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol. 2011, 22: 26-32. 10.1097/MOL.0b013e3283412279.CrossRefPubMed
5.
go back to reference Invitti C, Guzzaloni G, Gilardini L, et al: Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents. Diabetes Care. 2003, 26: 1118-1124.CrossRef Invitti C, Guzzaloni G, Gilardini L, et al: Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents. Diabetes Care. 2003, 26: 1118-1124.CrossRef
6.
go back to reference Alvarsson M, Wajngot A, Cerasi E, et al: K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Diabetologia. 2005, 48: 2262-2268. 10.1007/s00125-005-1929-6.CrossRefPubMed Alvarsson M, Wajngot A, Cerasi E, et al: K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Diabetologia. 2005, 48: 2262-2268. 10.1007/s00125-005-1929-6.CrossRefPubMed
7.
go back to reference Chen G, Liu C, Yao J, et al: Overweight, obesity, and their associations with insulin resistance and [beta]-cell function among Chinese: a cross-sectional study in China. Metabolism. 2010, 59: 1823-1832. 10.1016/j.metabol.2010.06.009.CrossRefPubMed Chen G, Liu C, Yao J, et al: Overweight, obesity, and their associations with insulin resistance and [beta]-cell function among Chinese: a cross-sectional study in China. Metabolism. 2010, 59: 1823-1832. 10.1016/j.metabol.2010.06.009.CrossRefPubMed
8.
go back to reference Jensen CC, Cnop M, Hull RL, et al: β-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes. 2002, 51: 2170-2178. 10.2337/diabetes.51.7.2170.CrossRefPubMed Jensen CC, Cnop M, Hull RL, et al: β-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes. 2002, 51: 2170-2178. 10.2337/diabetes.51.7.2170.CrossRefPubMed
9.
go back to reference Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. New Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. New Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
10.
go back to reference Department of Noncommunicable Disease Surveillance: Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part1.Diagnosis and classification of diabetes mellitus. 1999, Geneva: World Health Organization, Accessed February 26, 2010, at http://www.staff.ncl.ac.uk/philip.home/who-dmg.pdf. Department of Noncommunicable Disease Surveillance: Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part1.Diagnosis and classification of diabetes mellitus. 1999, Geneva: World Health Organization, Accessed February 26, 2010, at http://​www.​staff.​ncl.​ac.​uk/​philip.​home/​who-dmg.​pdf.
11.
go back to reference Luepker RV, Evans A, McKeigue P, et al: Cardiovascular survey methods. 2004, Geneva: World Health Organization, 3 Luepker RV, Evans A, McKeigue P, et al: Cardiovascular survey methods. 2004, Geneva: World Health Organization, 3
12.
go back to reference Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
13.
go back to reference Brunham LR, Kruit JK, Pape TD, et al: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007, 13: 340-347. 10.1038/nm1546.CrossRefPubMed Brunham LR, Kruit JK, Pape TD, et al: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007, 13: 340-347. 10.1038/nm1546.CrossRefPubMed
14.
go back to reference Gerin I, Dolinsky VW, Shackman JG, et al: LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. Biol Chem. 2005, 280: 23024-23031. 10.1074/jbc.M412564200.CrossRef Gerin I, Dolinsky VW, Shackman JG, et al: LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. Biol Chem. 2005, 280: 23024-23031. 10.1074/jbc.M412564200.CrossRef
15.
go back to reference Xia F, Gao X, Kwan E, et al: Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. Biol Chem. 2004, 279: 24685-24691. 10.1074/jbc.M314314200.CrossRef Xia F, Gao X, Kwan E, et al: Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. Biol Chem. 2004, 279: 24685-24691. 10.1074/jbc.M314314200.CrossRef
16.
go back to reference Hao M, Head WS, Gunawardana SC, et al: Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes. 2007, 56: 2328-2338. 10.2337/db07-0056.CrossRefPubMed Hao M, Head WS, Gunawardana SC, et al: Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes. 2007, 56: 2328-2338. 10.2337/db07-0056.CrossRefPubMed
17.
go back to reference Vikman J, Jimenez-Feltström J, Nyman P, et al: Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB. 2009, 23: 58-67. 10.1096/fj.08-105734.CrossRef Vikman J, Jimenez-Feltström J, Nyman P, et al: Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB. 2009, 23: 58-67. 10.1096/fj.08-105734.CrossRef
18.
go back to reference Zhang I, Qiao Q, Tuomilehto J, et al: Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study. Diabetes Res Clin Pract. 2008, 82: 364-377. 10.1016/j.diabres.2008.08.022.CrossRefPubMed Zhang I, Qiao Q, Tuomilehto J, et al: Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study. Diabetes Res Clin Pract. 2008, 82: 364-377. 10.1016/j.diabres.2008.08.022.CrossRefPubMed
19.
go back to reference Ishikawa M, Iwasaki Y, Yatoh S, et al: Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. Lipid Res. 2008, 49: 2524-2534. 10.1194/jlr.M800238-JLR200.CrossRef Ishikawa M, Iwasaki Y, Yatoh S, et al: Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. Lipid Res. 2008, 49: 2524-2534. 10.1194/jlr.M800238-JLR200.CrossRef
20.
go back to reference Rutti S, Ehses JA, Sibler RA, et al: Low and high density lipoproteins modulate function, apoptosis and proliferation of primary human and murine pancreatic beta cells. Endocrinology. 2009, 150: 4521-4530. 10.1210/en.2009-0252.CrossRefPubMed Rutti S, Ehses JA, Sibler RA, et al: Low and high density lipoproteins modulate function, apoptosis and proliferation of primary human and murine pancreatic beta cells. Endocrinology. 2009, 150: 4521-4530. 10.1210/en.2009-0252.CrossRefPubMed
21.
go back to reference Roehrich ME, Mooser V, Lenain V, et al: Insulin-secreting beta-cell dysfunction induced by human lipoproteins. Biol Chem. 2003, 278: 18368-18375. 10.1074/jbc.M300102200.CrossRef Roehrich ME, Mooser V, Lenain V, et al: Insulin-secreting beta-cell dysfunction induced by human lipoproteins. Biol Chem. 2003, 278: 18368-18375. 10.1074/jbc.M300102200.CrossRef
22.
go back to reference Jellinger PS: Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone. 2007, 8 (Suppl. 7): 30-42.CrossRef Jellinger PS: Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone. 2007, 8 (Suppl. 7): 30-42.CrossRef
23.
go back to reference Man ZW, Zhu M, Noma Y, et al: Impaired beta-Cell Function and Deposition of Fat Droplets in the Pancreas as a Consequence of Hypertriglyceridemia in OLETF Rat, a Model of Spontaneous NIDDM. Diabetes. 1997, 46: 1718-1724. 10.2337/diabetes.46.11.1718.CrossRefPubMed Man ZW, Zhu M, Noma Y, et al: Impaired beta-Cell Function and Deposition of Fat Droplets in the Pancreas as a Consequence of Hypertriglyceridemia in OLETF Rat, a Model of Spontaneous NIDDM. Diabetes. 1997, 46: 1718-1724. 10.2337/diabetes.46.11.1718.CrossRefPubMed
24.
go back to reference Zhou YP, Berggren PO, Grill V: A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes. 1996, 45: 5580-5586.CrossRef Zhou YP, Berggren PO, Grill V: A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes. 1996, 45: 5580-5586.CrossRef
25.
go back to reference Shimabukuro M, Zhou YT, Levi M, et al: Fatty acids induced β-cells apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA. 1998, 95: 2498-2502. 10.1073/pnas.95.5.2498.CrossRefPubMedPubMedCentral Shimabukuro M, Zhou YT, Levi M, et al: Fatty acids induced β-cells apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA. 1998, 95: 2498-2502. 10.1073/pnas.95.5.2498.CrossRefPubMedPubMedCentral
26.
go back to reference Oyadomari S, Takeda K, Masaki T, et al: Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. National Acad Sciences. 2001, 98: 10845-10850. 10.1073/pnas.191207498.CrossRef Oyadomari S, Takeda K, Masaki T, et al: Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. National Acad Sciences. 2001, 98: 10845-10850. 10.1073/pnas.191207498.CrossRef
27.
go back to reference Li XJ: Metabolic Syndrome insulin resistance syndrome. Relationship between insulin resistance with FFA and with blood lipid metabolism disorder. Edited by: Li XJ. 2006, 159-176. Volume 11 2nd Li XJ: Metabolic Syndrome insulin resistance syndrome. Relationship between insulin resistance with FFA and with blood lipid metabolism disorder. Edited by: Li XJ. 2006, 159-176. Volume 11 2nd
28.
go back to reference Davidson MH, Abate N, Ballantyne CM, et al: Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. Clinical Lipidology. 2008, 2: 436-446. 10.1016/j.jacl.2008.10.003.CrossRef Davidson MH, Abate N, Ballantyne CM, et al: Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. Clinical Lipidology. 2008, 2: 436-446. 10.1016/j.jacl.2008.10.003.CrossRef
29.
go back to reference Dobiásová M, Frohlichb J: The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma. Clin Biochem. 2001, 34: 583-588. 10.1016/S0009-9120(01)00263-6.CrossRefPubMed Dobiásová M, Frohlichb J: The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma. Clin Biochem. 2001, 34: 583-588. 10.1016/S0009-9120(01)00263-6.CrossRefPubMed
31.
go back to reference Heiss G, Tamir I, Davis CE, et al: Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation. 1980, 61: 302-315. 10.1161/01.CIR.61.2.302.CrossRefPubMed Heiss G, Tamir I, Davis CE, et al: Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation. 1980, 61: 302-315. 10.1161/01.CIR.61.2.302.CrossRefPubMed
Metadata
Title
Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study
Authors
Tianpeng Zheng
Yun Gao
Haoming Tian
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-634

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue